Optional exfoliating acids should generally be paused or reviewed when isotretinoin begins, rather than carried forward automatically. The treatment can make skin drier and more sensitive, and acids that were previously comfortable may now cause burning or peeling. The American Academy of Dermatology advises avoiding exfoliants such as glycolic, lactic and salicylic acid during treatment.
The issue is tolerability and the skin barrier, not a need to remove enough surface skin for the oral medicine to work. Visible flakes are not an instruction to exfoliate harder.
Find the ingredients behind the product names
| Product or ingredient | Where it may appear | Question to ask |
|---|---|---|
| Glycolic or lactic acid | AHA toner, serum, pad or mask | Is this optional exfoliation that should be paused? |
| Salicylic acid | BHA treatment, acne wash or spot product | Am I using more than one product containing it? |
| A combined resurfacing product | Several acids or another active ingredient | What is the complete exposure, not just the advertised main ingredient? |
| A gritty scrub or exfoliating brush | A replacement for an acid | Does the replacement create mechanical irritation instead? |
| A professional chemical peel | A planned procedure rather than ordinary daily care | Has the treating dermatologist assessed the procedure separately? |
Product names such as "renewing," "pore refining" or "clarifying" are not adequate ingredient lists. Record what is actually used, including cleansers, masks and products applied only once or twice a week.
Why layering can make the problem difficult to identify
A person may use an acid wash, a brightening serum and a weekend peel without recognizing them as three exposures. Each step can seem mild in isolation, yet the routine may be poorly tolerated during isotretinoin.
Spacing the products across the day does not prove that the combined irritation burden has been removed. Nor does applying them only to visible flakes establish that the areas are suitable for treatment.
Bring the routine to the prescribing team. If an active was specifically prescribed, ask how it fits the oral course instead of assuming the cosmetic advice overrides it or that it must continue unchanged. The clinician can give a defined plan for the actual products.
Distinguish peeling from the treatment goal
Dryness can produce flakes, tightness and soreness. Continuing acne can produce new lesions. Flat discoloration can remain after lesions heal. These findings have different implications, even when they are visible in the same area.
More exfoliation is not automatically useful for any of them. A strong acid applied to irritated skin may make the appearance and comfort worse without accelerating the relevant acne outcome.
Track the timing: did burning begin after a new product, after increased frequency or after the oral dose changed? That information can help the clinician interpret the problem, but timing alone does not prove which exposure is responsible.
What should replace the exfoliation routine?
The foundation is gentle cleansing, an appropriate moisturizer and sun protection. It does not need to be expensive or contain numerous active ingredients. The aim is a routine that the skin can tolerate consistently.
Do not replace an acid with a harsh scrub or a new "natural peel." A product's natural description does not establish that it is less irritating. If even a bland product stings on raw skin, the skin condition itself may need assessment rather than another round of product substitutions.
Persistent burning, fissures, marked redness or raw areas warrants advice. Severe swelling, blistering, an extensive eruption or other concerning symptoms requires appropriate assessment, not an assumption that ordinary exfoliation irritation explains everything.
A peel needs a separate decision
A home serum and a professional resurfacing procedure are not equivalent. Procedure depth, technique, indication and current skin condition matter. Evidence discussing selected procedures during or after isotretinoin cannot be generalized to every peel.
Tell the procedural clinician about current and recent isotretinoin use. Do not conceal it to avoid postponement, or treat a small home product as a test proving that a deeper procedure is safe.
When can an optional acid be reintroduced?
There is no universal calendar for every skin-care product and patient. Reintroduction should depend on skin recovery, the treatment plan and whether an active has a useful purpose. It should not occur automatically because a fixed number of days has passed.
When the dermatologist agrees that an active is appropriate, clarify the product and frequency. Avoid restarting several exposures together, since that makes an unwanted reaction harder to interpret.
The central decision is whether exfoliation adds a justified benefit to the current regimen. During isotretinoin, preserving a comfortable barrier often deserves more attention than removing texture aggressively, and a paused cosmetic step is not evidence that acne treatment has been weakened.